OGN News and Press, Organon & Co. From 01/02/24

2024-01-02 12:32:09 ET More on COVID vaccine makers BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics Novavax: Do Not Expect A Turnaround In 2024 BioNTech's COVID-19 Success Paves The Way For A Strong Drug Pipeline Moderna upgraded at Oppenhei...

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, 2024, at 1:30 p.m. PT. Investors, analys...

2023-12-21 01:08:28 ET Summary Pfizer stock has fallen 45% YTD as it has been impacted by the decline in revenue from COVID-19 products. The recent news about Danuglipron has added fuel to the fire. But is everything so bad when it comes to investing in the company for the long te...

2023-12-20 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-19 10:22:30 ET Summary Organon's stock has declined 32% since September, making it one of the worst performers in healthcare. The company reported mixed financial results, with 1% growth in product sales and a decline in total revenue. Organon's biggest challenge is de...

Organon becomes the sole distributor and promoter of Emgality ® ( galcanezumab) and RAYVOW ™ (lasmiditan) in Europe, building on strong commercial expertise in central nervous system disorders Expands Organon’s European product portfolio in a...

2023-12-15 09:45:07 ET United States Steel Corp. (X) X is trading UP for the last 5 days, and it at trading at $39.20 with volume of 3,114,701 and a one day change of $0.34 (0.86%). United States Steel Corp. has a 52-week low of 20.68 and a 52-week high of $35.03. The business's 50-...

2023-12-12 11:07:43 ET Summary Investors should consider tax-loss selling before December ends to offset capital gains. Two characteristics to consider for selling stocks are stocks bought at a higher price and broken companies with weak long-term prospects. Stock grades, sent...

2023-12-01 11:11:51 ET More on Kenvue, Organon, etc. Organon: It's Darkest Before The Dawn Organon & Co (OGN) Piper Sandler 35th Annual Healthcare Conference (Transcript) Kenvue: Dude, Where's My Dividend Growth? Kenvue may be activist target amid recent ...

2023-11-30 02:52:19 ET Summary Organon is a global healthcare company focused on women's health, with a diverse portfolio of prescription therapies and medical devices. OGN stock has been on a downward trend due to declining sales and excessive debt on the balance sheet. Despi...